Top 10,000 probesets ranked in association with disease traits across 19 brain regions. (XLSX 6710 kb
Table S1. Hippocampus transcription factor-centered network nodes and edges information. (XLSX 40 kb
The classification of AD-associated genes and AD-non associated genes. C1-AD: probable pathogenic ge...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
Table S2. List of 30âAD-specific modules and 31 normal-specific modules. (XLSX 27 kb
Table S3. Enrichment of AD-risk variants at H3K4me1 peaks from Roadmap Epigenomics Consortium data. ...
Table S3. Enriched GO terms (p-value<0.01) of all condition-specific modules. Table S4. Enriched KEG...
Table S1. Comparison of module genes identified by lmQCM and WGCNA from GSE48350 AD samples. (XLSX 1...
Table S2. Enrichment of AD-risk variants at H3K27ac peaks from Roadmap Epigenomics Consortium data. ...
Contains compilations of lists of (disease) genes previously implicated in relevant disease. The ent...
Table S4. Enrichment of AD-risk variants at H4K3me3 peaks from Roadmap Epigenomics Consortium data. ...
Table S1. Enrichment of AD-risk variants at DHSs from Roadmap Epigenomics Consortium data. (XLSX 36 ...
Table S5. Modules with targets of specific differentially expressed TF enriched in certain pathways....
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Figure S1. SDS-PAGE of Brain Homogenates. Dorsolateral prefrontal cortex (DLPFC) brain tissue homoge...
Table S1. Hippocampus transcription factor-centered network nodes and edges information. (XLSX 40 kb
The classification of AD-associated genes and AD-non associated genes. C1-AD: probable pathogenic ge...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
Table S2. List of 30âAD-specific modules and 31 normal-specific modules. (XLSX 27 kb
Table S3. Enrichment of AD-risk variants at H3K4me1 peaks from Roadmap Epigenomics Consortium data. ...
Table S3. Enriched GO terms (p-value<0.01) of all condition-specific modules. Table S4. Enriched KEG...
Table S1. Comparison of module genes identified by lmQCM and WGCNA from GSE48350 AD samples. (XLSX 1...
Table S2. Enrichment of AD-risk variants at H3K27ac peaks from Roadmap Epigenomics Consortium data. ...
Contains compilations of lists of (disease) genes previously implicated in relevant disease. The ent...
Table S4. Enrichment of AD-risk variants at H4K3me3 peaks from Roadmap Epigenomics Consortium data. ...
Table S1. Enrichment of AD-risk variants at DHSs from Roadmap Epigenomics Consortium data. (XLSX 36 ...
Table S5. Modules with targets of specific differentially expressed TF enriched in certain pathways....
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Figure S1. SDS-PAGE of Brain Homogenates. Dorsolateral prefrontal cortex (DLPFC) brain tissue homoge...
Table S1. Hippocampus transcription factor-centered network nodes and edges information. (XLSX 40 kb
The classification of AD-associated genes and AD-non associated genes. C1-AD: probable pathogenic ge...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...